Variants in genes like GLP1R (rs6923761) and GIPR (rs1800437) affect receptor sensitivity and medication efficacy, meaning some patients achieve results faster on standard doses while others benefit from dose optimization or alternative compounds
Proporciona volumen y elasticidad a la piel
Both are designed to support fat loss and metabolic regulation, but their mechanisms and clinical potential are quite different
The cerebrovascular benefits of GLP-1 RAs were independent of age (over or under 60 years), BMI (over or under the median of 32 kg/m 2 ) and HbA 1c (over or under the median of 66 mmol/mol) at baseline
Linge, J., Birkenfeld, A .L
VicaEmpa combination treatment is a novel therapeutic strategy for CKD that may afford superior benefits for clinical kidney and cardiovascular outcomes over SGLT2 inhibition alone To view or add a comment, sign in A New Oral Option for LDL-C Lowering in HeFH Patients with heterozygous familial hypercholesterolemia (HeFH) remain at high ASCVD risk due to lifelong elevated LDL-C